1. Home
  2. LXRX vs BMM Comparison

LXRX vs BMM Comparison

Compare LXRX & BMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.32

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

BMM

Blue Moon Metals Inc. Common Shares

N/A

Current Price

$7.19

Market Cap

654.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LXRX
BMM
Founded
1995
2007
Country
United States
Canada
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
703.3M
654.0M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
LXRX
BMM
Price
$2.32
$7.19
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.15
N/A
AVG Volume (30 Days)
2.9M
127.7K
Earning Date
05-01-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
77.78
N/A
EPS
N/A
N/A
Revenue
$49,803,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
60.24
N/A
52 Week Low
$0.52
$3.47
52 Week High
$2.53
$8.63

Technical Indicators

Market Signals
Indicator
LXRX
BMM
Relative Strength Index (RSI) 70.85 51.55
Support Level $1.44 $4.79
Resistance Level N/A $8.53
Average True Range (ATR) 0.16 0.39
MACD 0.08 -0.09
Stochastic Oscillator 80.20 35.31

Price Performance

Historical Comparison
LXRX
BMM

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About BMM Blue Moon Metals Inc. Common Shares

Blue Moon Metals Inc is a Canadian exploration stage company which is focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The company also holds the Yava polymetallic project in Nunavut that is in the same volcanic lithologies and south of Glencore's Hackett River deposit. The company is focusing on advancing the Blue Moon and Yava properties.

Share on Social Networks: